The mobile platform allows clinicians in primary care and at-home care to capture retinal images to screen for several eye diseases in minutes. Diseases the platform can screen for include diabetic retinopathy, glaucoma and age-related macular degeneration.
Spect said it will use the funds to further develop the platform’s AI capabilities, grow its team and expand diagnostic access and partnerships within the healthcare industry.
